Trials for the Russian adenovirus-based vaccine are set to commence in the UAE, the Abu Dhabi Media Office announced on Monday.
“The results of the UAE trial will be combined with the results of the of the trial in Russia and other countries,” Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF) said in the statement, adding that interim results will be published before the end of November.
Plans to launch Phase III trials of Sputnik V in India suffered a setback last week after India’s drug regulator said early-stage trials – already conducted in Russia – must be done locally first too.
With inputs from Reuters
Phase III trials for the Russian adenovirus-based vaccine are to commence in #UAE. The UAE clinical trials will be conducted by @DoHSocial, supervised by @mohapuae, with medical protocols handled by @SEHAHealth. pic.twitter.com/KzAoGyvaHZ